Institutional investors purchased a net $1.3 million shares of TARO during the quarter ended December 2013. This may signal that the smart money is gaining interest in this company as the 9.57% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Generic industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ISZO CAPITAL MANAGEMENT LP Bought 1.1 Million shares of Taro Pharmaceutical Indus...
HOTCHKIS & WILEY CAPITAL MANAGEM... Bought 91.3 Thousand shares of Taro Pharmaceutical Indus...